149 related articles for article (PubMed ID: 18235041)
1. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.
Rezaei N; Aghamohammadi A; Siadat SD; Moin M; Pourpak Z; Nejati M; Ahmadi H; Kamali S; Norouzian D; Tabaraei B; Read RC
Clin Vaccine Immunol; 2008 Apr; 15(4):607-11. PubMed ID: 18235041
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.
Rezaei N; Siadat SD; Aghamohammadi A; Moin M; Pourpak Z; Norouzian D; Mobarakeh JI; Aghasadeghi MR; Nejati M; Read RC
Clin Vaccine Immunol; 2010 Apr; 17(4):524-8. PubMed ID: 20106999
[TBL] [Abstract][Full Text] [Related]
3. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease.
Rezaei N; Aghamohammadi A; Read RC
Iran J Allergy Asthma Immunol; 2008 Dec; 7(4):231-4. PubMed ID: 19052353
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
[TBL] [Abstract][Full Text] [Related]
5. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.
Rezaei N; Haji-Molla-Hoseini M; Aghamohammadi A; Pourfathollah AA; Moghtadaie M; Pourpak Z
J Clin Immunol; 2008 Jan; 28(1):78-84. PubMed ID: 17912490
[TBL] [Abstract][Full Text] [Related]
6. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications.
Vodjgani M; Aghamohammadi A; Samadi M; Moin M; Hadjati J; Mirahmadian M; Parvaneh N; Salavati A; Abdollahzade S; Rezaei N; Srrafnejad A
J Investig Allergol Clin Immunol; 2007; 17(5):321-8. PubMed ID: 17982925
[TBL] [Abstract][Full Text] [Related]
7. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.
Borrow R; Andrews N; Goldblatt D; Miller E
Infect Immun; 2001 Mar; 69(3):1568-73. PubMed ID: 11179328
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production by activated T cells in common variable immunodeficiency.
Rezaei N; Aghamohammadi A; Nourizadeh M; Kardar GA; Pourpak Z; Zare A; Read RC
J Investig Allergol Clin Immunol; 2010; 20(3):244-51. PubMed ID: 20635790
[TBL] [Abstract][Full Text] [Related]
9. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.
Andrews N; Borrow R; Miller E
Clin Diagn Lab Immunol; 2003 Sep; 10(5):780-6. PubMed ID: 12965904
[TBL] [Abstract][Full Text] [Related]
10. The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.
Idoko OT; Okolo SN; Plikaytis B; Akinsola A; Viviani S; Borrow R; Carlone G; Findlow H; Elie C; Kulkarni PS; Preziosi MP; Ota M; Kampmann B
Vaccine; 2014 Jul; 32(33):4220-7. PubMed ID: 24863486
[TBL] [Abstract][Full Text] [Related]
11. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets.
Yazdani R; Seify R; Ganjalikhani-Hakemi M; Abolhassani H; Eskandari N; Golsaz-Shirazi F; Ansaripour B; Salehi E; Azizi G; Rezaei N; Aghamohammadi A
Allergol Immunopathol (Madr); 2017; 45(2):183-192. PubMed ID: 27717724
[TBL] [Abstract][Full Text] [Related]
12. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
[TBL] [Abstract][Full Text] [Related]
13. Active vaccination in patients with common variable immunodeficiency (CVID).
Goldacker S; Draeger R; Warnatz K; Huzly D; Salzer U; Thiel J; Eibel H; Schlesier M; Peter HH
Clin Immunol; 2007 Sep; 124(3):294-303. PubMed ID: 17602874
[TBL] [Abstract][Full Text] [Related]
14. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
[TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological features of common variable immunodeficiency in Mexican patients.
Ramírez-Vargas N; Arablin-Oropeza SE; Mojica-Martínez D; Yamazaki-Nakashimada MA; de la Luz García-Cruz M; Terán-Juárez LM; Cortés-Grimaldo RM; Torres-Lozano C; Madrigal-Beas I; Ortega-Cisneros M; Vargas-Camaño ME; Staines-Boone T; Pietropaolo-Cienfuegos D; Berrón-Ruiz L; Espinosa-Rosales FJ; Guevara-Cruz M; Blancas-Galicia L
Allergol Immunopathol (Madr); 2014; 42(3):235-40. PubMed ID: 23578780
[TBL] [Abstract][Full Text] [Related]
18. Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.
Jokhdar H; Borrow R; Sultan A; Adi M; Riley C; Fuller E; Baxter D
Clin Diagn Lab Immunol; 2004 Jan; 11(1):83-8. PubMed ID: 14715549
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients.
Bagheri Y; Vosughi A; Azizi G; Yazdani R; Kiaee F; Hafezi N; Alimorad S; Khoshmirsafa M; Seif F; Hassanpour G; Abolhassani H; Aghamohammadi A
Immunol Lett; 2019 Jun; 210():55-62. PubMed ID: 31059734
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications.
Aydogan M; Eifan AO; Gocmen I; Ozdemir C; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2008; 18(4):260-5. PubMed ID: 18714533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
